Epoetin- Reduces Postoperative Length of Stay in Patients Undergoing Knee Replacement (Englisch)
In:
VALUE IN HEALTH
;
2
, 1
;
19
;
1999
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Epoetin- Reduces Postoperative Length of Stay in Patients Undergoing Knee Replacement
-
Erschienen in:VALUE IN HEALTH ; 2, 1 ; 19
-
Verlag:
- Neue Suche nach: VALUE IN HEALTH
-
Erscheinungsdatum:01.01.1999
-
Format / Umfang:19 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 2, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 3
-
ISPOR Inaugural European Conference: An OverviewRindress, D. et al. | 1999
- 5
-
Review of Legislation Relating to Promotion of Medicinal Products in the European Union - Are Health Economics Data Covered?| 1999
- 5
-
Identifying Initial Diagnosis in Database Research| 1999
- 6
-
Cost-Effectiveness Analysis of High-Dose Chemotherapy with Hematopoietic Rescue as Primary Treatment for Metastatic Breast Cancer| 1999
- 6
-
A New Method for Expressing Survival and Life Expectancy in Cancer Patients| 1999
- 6
-
How Do Patients Make Satisfaction Judgments? Answers from Structural Equation Modeling| 1999
- 7
-
Practice Patterns of Chemotherapy Usage and Associated Neutropenia and Febrile Neutropenia (FN) in Europe| 1999
- 7
-
An 11-Year, Controlled Study of Healthcare Resource Use and Mortality for Patients with Parkinson's Disease| 1999
- 8
-
Economic Evaluation of Acamprosate in Maintaining Abstinence in Alcohol-Dependent Patients| 1999
- 8
-
Cross-Cultural Adaptation of the Migraine-Specific Quality of Life Questionnaire (MSQ) in 14 Languages| 1999
- 8
-
Cost-Utility Analysis of Laparoscopic versus Open Surgery for Colonic Disease| 1999
- 9
-
DIGEST International Survey: Impact of Upper Gastrointestinal Symptoms on Resource Utilization and Quality of Life| 1999
- 9
-
The Effect of an Open Access Endoscopy Service on Prescribing Costs of Ulcer-Healing Drugs| 1999
- 10
-
Quality of Life of Asthma Patients Relative to Asthma Severity| 1999
- 10
-
Compliance with Inhaled Corticosteroids and Hospitalization for Asthma| 1999
- 10
-
Effectiveness of Oral Ciprofloxacin in the Treatment of Exacerbations of Chronic Airway Diseases| 1999
- 11
-
Is Trimethoprim Resistance an Outcome of Community Antibiotic Prescribing?| 1999
- 11
-
Cross-Cultural Adaptation of the Pediatric Asthma Caregiver Quality of Life Questionnaire (PACQLQ) in 19 Countries| 1999
- 12
-
Ciprofloxacin Is More Successful and Cost-Effective than Trimethoprim/Sulfamethoxazole in the Oral Ambulatory Treatment of Women with Uncomplicated Acute Pyelonephritis| 1999
- 12
-
Preliminary Quality-of-Life Evaluation of the German SAT Trial: Comparison of SF-36, EuroQol, Time Trade-Off Method, and Willingness to Pay Method| 1999
- 12
-
Cost-Effectiveness of Treating High-Risk Individuals, Aged 45-65, with Statins in Germany for Primary and Secondary Prevention of Coronary Heart Disease| 1999
- 13
-
Improved Myocardial Protection during Coronary Bypass Surgery Shortens Hospital Stay and Saves Costs| 1999
- 13
-
Utilization of ACE Inhibitors in Congestive Heart Failure among the Elderly in Quebec| 1999
- 14
-
Road Traffic Accidents Are Associated with Benzodiazepine Use| 1999
- 14
-
Economic Assessment of a Prophylactic Treatment of Recurrence of Ischemic Accidents by Lysine Acetylsalicylate| 1999
- 14
-
Outcome of Acute Myocardial Infarction Patients with Maximal Individual Therapy (Mitra-Study)| 1999
- 15
-
Assessing the Saskatchewan Database for Outcomes Studies of Depression and Its Treatment| 1999
- 15
-
New Benzodiazepine Use Is Associated with an Age-Related Risk of Hospitalization with Fracture and Other Trauma: A Population-Based Study| 1999
- 16
-
Economic Impact of Agitated and Aggressive Behaviors of Elderly Individuals Dwelling in the Community in France: 1. Epidemiology| 1999
- 16
-
Economic Impact of Agitated and Aggressive Behaviors of Elderly Individuals Dwelling in the Community in France: 2. Cost Analysis| 1999
- 16
-
Cost-Utility Analysis of Risperidone in Chronic Schizophrenia| 1999
- 17
-
Patient-Held Instruments for Recording Ambulatory Care Resource Use: Experience in Patients with Diabetic Foot Ulcers| 1999
- 17
-
Self-Monitoring of Blood Glucose in Diabetes: Is It Worth It?| 1999
- 18
-
Assessing the Value of Epoetin- versus Autologous Blood Donation in Orthopedic Surgery: A Feasibility Study of Contingent Valuation| 1999
- 18
-
Measuring the Impact of Diabetic Foot Ulcers on Quality of Life from the Patient's Perspective| 1999
- 18
-
Antithyroid Drugs or Radioiodine as First-Line Therapy of Graves' Hyperthyroidism in a Country with Strict Regulations for Radiation Protection?| 1999
- 19
-
Epoetin- Reduces Postoperative Length of Stay in Patients Undergoing Knee Replacement| 1999
- 20
-
Pharmacoeconomic Efficiency of the Use of Protease Inhibitors for Hospital Inpatients with AIDS| 1999
- 20
-
The Cost-Effectiveness of Itraconazole Solution in the Treatment of Oral Candidiasis in HIV/AIDS Patients: An International Comparison| 1999
- 21
-
Economic Consequences of Monoclonal Antibody 17-1A Adjuvant Therapy of Resected Dukes' C Colorectal Carcinoma in Germany| 1999
- 21
-
Quality of Life in Hodgkin's Disease: Results from the EORTC and GHSG Trials| 1999
- 21
-
Outcome of Monoclonal Antibody 17-1A Adjuvant Therapy of Resected Colon Cancer Dukes' C in Germany: A Subgroup Analysis| 1999
- 22
-
Cost Estimation of Severe Neutropenia in Belgium| 1999
- 22
-
Cost-Effectiveness of Gemcitabine as First-Line Therapy for Patients with Advanced Pancreatic Cancer| 1999
- 22
-
Cost-Minimization in the Use of Colony-Stimulating Factors (CSFs) Based on Clinical Prediction Models (CPMs)| 1999
- 23
-
The Relationship between Profile-Based Quality of Life Scores and EuroQol-5D Scores in Breast Cancer Surgery Patients| 1999
- 23
-
Quality of Life (QoL) of Patients with Low-Grade Non-Hodgkin's Lymphoma (Ig-NHL) Treated with Fludarabine (F) or Cyclophosphamide-Vincristine-Prednisone (CVP)| 1999
- 24
-
Adapting Economic Analyses from One Country to Another: Do the WOSCOPS UK Findings Hold in Belgium?| 1999
- 24
-
Cost-Effectiveness of Lipid Modulator Agents| 1999
- 24
-
Efficacy of Cardiac Rehabilitation Therapy: A Prospective Multicenter Cohort Study| 1999
- 25
-
Potential Cost Savings of the 4 French Infiniti Catheter in Diagnostic Coronary Angiography| 1999
- 25
-
Measuring Disease-Specific Symptom Impact: Development of the Atrial Fibrillation Impact Scale (AFIS)| 1999
- 25
-
The Economic Impact of Hypertension Study from the Pistoia Project| 1999
- 26
-
Cross-Cultural Adaptation of the Seattle Angina Questionnaire (SAQ) in 11 Countries| 1999
- 26
-
Impact of Clinical Sensitivity Analysis in an Evaluation of Primary Prevention of Coronary Heart Disease in Germany| 1999
- 27
-
A Health Economic Evaluation of Hormone Replacement Therapy in Belgium| 1999
- 27
-
Willingness to Pay of Patients with Painful-Irritable Bladder Syndrome| 1999
- 27
-
Comparison of the Epidemiology and Costs Associated with Primary Prevention of Coronary Heart Disease in Five European Countries| 1999
- 28
-
The Effects of Ulcer-Healing Drug Coprescription on NSAID-Induced Gastrointestinal Events: A Record Linkage Cohort Study| 1999
- 28
-
Evaluating Clinical Outcomes of GERD Treatment Options Using Decision Analysis| 1999
- 29
-
Cross-Cultural Adaptation of the Patient Assessment of Constipation-Symptom Questionnaire (PAC-SYM)| 1999
- 29
-
Rate of Gastroprotective Agent Use, Diagnostic Tests, and Hospitalizations among Elderly Patients Who Started Arthrotec, a Fixed Combination of Misoprostol and Diclofenac| 1999
- 30
-
Cost-Effectiveness of Levofloxacin versus Clarithromycin in Patients Evaluable for Clinical Efficacy in the Treatment of Acute Bacterial Sinusitis| 1999
- 30
-
Compliance with American Diabetic Association (ADA) Recommendations in a Type 2 Diabetic Population in an Academic Family Medicine Center| 1999
- 30
-
Cost-Minimization Analysis of Cefamandole and Tobramycin versus Standard Therapy in the Treatment of Patients with Local Appendicular Peritonitis| 1999
- 31
-
Annual Direct Costs of Psychotropic Medications for the Treatment of Psychiatric Disorders in India| 1999
- 31
-
Clinical and Economic Characterization of Family Medicine Patients Receiving Antidepressant Drugs| 1999
- 32
-
The Budget Impact Pharmacotherapy Selection for Major Depressive Disorder: A Multinational Study| 1999
- 32
-
Cost-Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France| 1999
- 33
-
Cross-Cultural Adaptation of the International Index of Erectile Function (IIEF) in 31 Countries| 1999
- 33
-
Cost of Alzheimer's Disease Care in the United Kingdom| 1999
- 33
-
Development of a New Disease-Specific Quality of Life Scale for Use in Schizophrenia| 1999
- 34
-
Results of Disease Management in Headache Treatment| 1999
- 34
-
A UK Primary Care Database (UKPCD)-UK MediPlus as a Readily Available Research Tool for Determining the Incidence and Prevalence of Multiple Sclerosis, Its Treatment, Prescription Costs, and Referrals in UK Practice| 1999
- 34
-
Effect of Risperidone on the Cost of Nursing Home Care for Residents with Behavioral and Psychological Signs and Symptoms| 1999
- 35
-
Quality of Life and Functional Status Measures in Advanced Parkinson's Patients Treated with Pramipexole, Bromocriptine, or Placebo| 1999
- 35
-
A Foundation Study for Cost-Effectiveness Analysis: The Definition of Economic Parameters and Clinical Endpoints in Parkinson's Disease| 1999
- 36
-
Cross-Cultural Adaptation of the Functional Assessment of Multiple Sclerosis (FAMS) Questionnaire in Nine Countries| 1999
- 36
-
Impact of a Cost-Sharing Drug Insurance Plan on Drug Utilization among Individuals Receiving Social Assistance| 1999
- 37
-
The Effect of Age on Cost-Effectiveness in the Treatment of Moderate Asthma| 1999
- 37
-
Characteristics of Chronic Airway Disease Patients Started on Nebulized Ipratropium Solution| 1999
- 37
-
Cost-Effectiveness of Pramipexole in Parkinson's Disease in Three Countries| 1999
- 38
-
Incremental Cost of Disease in Nosocomial Pneumonia from a Hospital's Perspective: A Feasibility Study| 1999
- 38
-
Economic Impact of Smoking in Germany| 1999
- 38
-
Cost-Effectiveness Analysis of a Fixed Combination (Diclofenac + Misoprostol) in the Prevention of Gastropathy in Arthritis Patients in Belgium| 1999
- 39
-
Cost of Illness in Early Rheumatoid Arthritis Stratified for Social Status| 1999
- 39
-
Quality of Life Scores as Predictors of Future Healthcare Resource Use in Patients with Arthritis| 1999
- 40
-
Survival Gains and Degree of Therapeutic Innovation| 1999
- 40
-
Medication Compliance and Expenditure Impact Associated with Pharmacist's Cognitive Service Interventions| 1999
- 40
-
Running Cost of Treating a Patient in a General Medical Ward in Sultan Qaboos University Hospital in Oman| 1999
- 41
-
Using a Surrogate Sample to Derive Patient Preferences for a Cost-Utility Analyses in a Randomized Clinical Trial| 1999
- 41
-
Linking HRQOLS to Large National Data Sets: EuroQol and HUI Indices| 1999
- 42
-
Meta-Analysis of Economic Evaluations: A Methodological Approach and Case Study| 1999
- 42
-
Advanced Sensitivity Analysis by the Integration of Point-Sensitivity and Range-Sensitivity Using Probability Distributions| 1999
- 42
-
Diminishing the Cost of Highly Prescribed Drugs in the Comunidad Valenciana (Spain)| 1999
- 44
-
Monte Carlo Simulation in Healthcare Models| 1999
- 44
-
A Natural History of Alzheimer's Disease: Path-Dependent Evaluation of Clinical and Economic Outcomes Using Decision Database Methodology| 1999
- 45
-
Decision Analysis in Cancer Therapy, A New Way for Evaluation Outcomes with the Analytic Hierarchy Process (AHP)| 1999
- 45
-
The Appropriateness of Common Medical Data Sources: Randomized Trials, Meta-Analyses, Epidemiological and Observational Studies for Pharmacoeconomic Analyses| 1999
- 45
-
The Development and Implementation of Formulary Submission Guidelines for Managed Care in the United States| 1999
- 45
-
Developing Interactive Computer Software for Evaluating the Economic and Clinical Outcomes of Various Treatment Strategies| 1999
- 46
-
Pro and Con: Use of Data from Foreign Pharmacoeconomic Investigations in Russia| 1999
- 46
-
Standardization in the Public Health System of Russia: The First Experience| 1999
- 47
-
Standard Procedures for Economic Evaluation: Using a Computer Program for Reporting Economic Evaluations Results (REER)| 1999
- 47
-
The Use of Proxies to Collect Healthcare Resources and Quality of Life Data| 1999
- 47
-
The DARTS Diabetes Database: How Can Quality of Life Measurements for Outcomes Research Be Incorporated?| 1999
- 48
-
Estimating Drug Effects: From Clinical Trial Results to Actual Practice| 1999
- 48
-
Health Status and Quality of Life Measures in International Clinical Research| 1999
- 48
-
Estimating Population Budget and Health Impacts of New Treatments| 1999
- 49
-
Economic Evaluation of Rehabilitation Programs: The Perspective of Social Old Age Insurance Funds in Germany| 1999
- 49
-
Designing an International Piggyback Study: Providing the Foundation| 1999
- 49
-
Handling Survival Data in Cost-Effectiveness Analysis| 1999
- 50
-
The Bootstrap Statistical Method for the Pharmacoeconomic Cost Analysis of Skewed Data| 1999
- 50
-
Self-Reported Resource Utilization Data in Pharmacoeconomic Trials: Their Use and Impact on Study Validity| 1999